Fundz

Tempest Therapeutics announced it raised $2 Million in an initial filing from an offering of $2 Million

PUBLIC · TPSTApr 03, 2026

Amount Raised

$2 Million

Round Type

Seed

San FranciscoBiotechnologyHealthcareHealth CareTherapeuticsBiopharma

Company Information

Company

Tempest Therapeutics

Location

ONE SANSOME STREET

San Francisco, California, United States

About

Tempest Therapeutics is a development-stage biotechnology company.

Fundz sees it the moment Tempest Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsMatt A., President and CEO hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Tempest Therapeutics's next move

See what Strategic adds

Tempest Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.